Fluorometholone Forte
FDA Approves Retinal Implant for Rare Genetic Eye Disease »
"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
Read the FDA Approves Retinal Implant for Rare Genetic Eye Disease article »
FML Forte
CONTRAINDICATIONS
FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
Last reviewed on RxList: 7/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional FML Forte Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
